Contineum Therapeutics, Inc. (CTNM) Misses Q1 EPS by 20c

Contineum Therapeutics, Inc. (NASDAQ: CTNM) reported Q1 EPS of ($0.62), $0.20 worse than the analyst estimate of ($0.42).

For earnings history and earnings-related data on Contineum Therapeutics, Inc. (CTNM) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• GE Vernova T&D India (GVTD:IN) PT Raised to INR5,300 at Emkay Global
• Goldman Sachs sees refinery exemptions boosting DK cash flow